XRAY DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action

New York, NY–(Newsfile Corp. – January 22, 2025) – WHY? The Rosen Law Firm, a global investor protection law firm, reminds purchasers of Dentsply Sirona Inc. (NASDAQ: XRAY ) common stock from May 6, 2021 through November 6, 2024, both dates inclusive (“Class Period “), important January 27, 2025 lead plaintiff deadline.

SO WHAT? If you purchased Dentsply Sirona common stock during the Class Period, you may be entitled to compensation without payment of any cash fees or expenses through a contingency fee arrangement.

WHAT TO DO NEXT? To join the Dentsply Sirona course, visit https://rosenlegal.com/submit-form/?case_id=31762 or call Philip Kim, Esq. 866-767-3653 or email email case@rosenlegal.com for more information.A class action lawsuit has already been filed. If you want to act as the main plaintiff, you must move to court no later than January 27, 2025. A lead plaintiff is a representative party acting on behalf of other class members in leading the litigation.

WHY CHOOSE ROSEN LAW? We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, notifying companies do not have comparable experience, resources or the recognition of any meaningful peers. Many of these firms do not actually handle securities class actions, but are simply brokers who refer clients or partners to law firms that actually handle litigation. Be Wise When Choosing Counsel The Rosen Law Firm represents investors worldwide, focusing its practice in securities class actions and shareholder derivative litigation 1 rating by ISS Securities Class Action: (WA:) Services for securities class actions in 2017. The company has been ranked in the top 4 every year since 2013. In 2019 alone, the company secured more than 438 million dollars for investors Founding partner Lawrence Rosen was named a titan of plaintiffs’ counsel by law360.Many of the firm’s attorneys have been recognized By Lawdragon and Super Lawyers.

DETAILS OF THE CASE. According to the lawsuit, during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose material facts necessary to make the statements made, given the circumstances in which they were made, not false and misleading.In fact, Byte aligners was causing serious patient injury since at least May 2021, as seen in injury reports submitted by Dentsply Sirona during 2024 to the U.S. Food and Drug Administration (“FDA”) At least part of the problem was that customer service officers and supervising dentists were encouraged to register patients who had other dental problems that would lead to: they are not eligible for Byte treatment.As a result, the defendants’ positive statements regarding Byte’s extensive network of clients and dentists’ treatment were materially misleading and/or lacked reasonable basis. hid the fact that its high conversion rates were due to sales incentives to sign up patients. When the real details came to market, the suit alleges, investors suffered losses.

To join the Dentsply Sirona course, visit https://rosenlegal.com/submit-form/?case_id=31762 or call Philip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com.

No class has been certified. You are not represented by an attorney. You may choose to remain a member of the class and do nothing at this time potential future recovery is not dependent on serving as lead plaintiff.

Follow us for updates on LinkedIn at https://www.linkedin.com/company/the-rosen-law-firm , on Twitter at https://twitter.com/rosen_firm or on Facebook ( NASDAQ: ). https:/ /www.facebook.com/rosenlawfirm/.

Advertisement of a lawyer. Previous results do not guarantee a similar result.

——————————

Contact information.

To view the original version of this press release, visit https://www.newsfilecorp.com/release/238134